Evidence map›Paper›PMID 29667531›Full record

ArticleJournal of the International Association of Providers of AIDS Care

Is Tobacco Use Associated with Neurocognitive Dysfunction in Individuals with HIV?

Billy Tsima, Sarah Jane Ratcliffe, Robert Schnoll, Ian Frank, Dennis Larry Kolson, Robert Gross

Open access · goldAbstract read
In one paragraph

Article in Journal of the International Association of Providers of AIDS Care. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Cigarette smoking is associated with reduced neuroinflammation and better cognitive control in people living with HIV.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  4. Review
  5. Article
  6. Neuroimaging the Neuropathogenesis of HIV.Current HIV/AIDS reports · 2021
    Review
  7. Independent and Combined Effects of Nicotine or Chronic Tobacco Smoking and HIV on the Brain: A Review of Preclinical and Clinical Studies.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020
    Review
  8. Bidirectional Associations among Nicotine and Tobacco Smoke, NeuroHIV, and Antiretroviral Therapy.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Billy Tsima1 Department of Family Medicine & Public Health, University of Botswana, Gaborone, Botswana.
Sarah Jane Ratcliffe2 Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, USA.
Robert Schnoll3 University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Ian Frank3 University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Dennis Larry Kolson3 University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Robert Gross4 Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA.
University of Pennsylvania · USUniversity of Botswana · BW

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DAVID S METZGER · 1999 to 2026
$78.6M
Penn Mental Health AIDS Research CenterP30MH097488 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI Karine Dube · 2013 to 2026
$23.5M
Regulation of Heme Oxygenase in HIV/HAND PathogenesisR01MH111389 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI KOLSON, DENNIS LARRY · 2016 to 2020
$2.9M
Oxidative Stress, Immune Activation, and Therapeutic Targeting in HIV/HANDR01MH104134 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI KOLSON, DENNIS LARRY · 2014 to 2018
$2.3M
HIV Research Training Program for BotswanaD43TW009781 · FIC · UNIVERSITY OF PENNSYLVANIA · PI GROSS, ROBERT · 2014 to 2018
$1.7M
FIC NIH HHS D43 TW009781NIAID NIH HHS P30 AI045008NIMH NIH HHS P30 MH097488NIMH NIH HHS R01 MH104134NIMH NIH HHS R01 MH111389
6 · The paper itself

Abstract

introductionThe prevalence of HIV-associated neurocognitive disorders continues to rise despite the widespread use of antiretroviral therapy. We aimed to define the risk of neurocognitive dysfunction among smokers relative to nonsmokers.

methodsWe conducted a retrospective cohort study including HIV-infected adults ages 21 to 65 years. The Mental Alternation Test (MAT) was the primary outcome. The odds of cognitive impairment were compared using random-effects logistic regression to adjust for potential confounders.

resultsOf 3033, 1486 (49%) were smokers. The odds ratio for the association between smoking and cognitive impairment was 1.12 (95% confidence interval: 0.85-1.49). Nonsmokers had a higher median MAT score relative to smokers ( P = .01).

conclusionThere was no evidence that HIV-infected smokers had greater neurocognitive dysfunction relative to HIV-infected nonsmokers. While tobacco use remains an important health risk issue to address in the HIV population, it may not represent a risk factor for neurocognitive impairment.

Indexed as

Neuropsychological TestsAdultAgedAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveCognitive DysfunctionFemaleHIV InfectionsHumansLogistic ModelsMaleMiddle AgedOdds RatioPrevalenceRetrospective StudiesRisk FactorsAnti-HIV AgentsHANDHIV-1neurocognitive dysfunctionsmokingtobacco

Identifiers

PMID29667531
PMCPMC6493327
OpenAlexW2801438293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.